(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GOZELLIX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

GOZELLIX

ST13

US500000079402087

Class

5, 10

Filing

79402087

Registration

7602824

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

16

Latest update

07/30/2026

Trademark type

Word

Nice classes

5, 10

Filing date

03/20/2024

Registration date

12/17/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/17/2024

Last transaction

07/30/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

AU

Examiner

RUTLAND, BARBARA A

Law office

L10

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Telix Pharmaceuticals Limited

Representatives

Telix Pharmaceuticals Limited

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Chemical preparations for pharmaceutical purposesdiagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imagingdiagnosing and monitoring of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imagingdiagnosing and monitoring of cancer.

Class 10

Medical apparatusinfusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposesdrug delivery devices sold emptysyringes and infusion sets for diagnostic radiopharmaceuticals; medical devices for treating cancer; diagnostic imaging apparatus for medical use.

Publications

History of USPTO decisions and trademark events.

16 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/30/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

01/22/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/22/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/07/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

01/07/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/01/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/16/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

12/17/2024

PUBO

PUBLISHED FOR OPPOSITION

10/29/2024

NPUB

NOTICE OF PUBLICATION

10/09/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/22/2024

DOCK

ASSIGNED TO EXAMINER

09/20/2024

MAFR

APPLICATION FILING RECEIPT MAILED

08/20/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/20/2024

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

08/15/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

08/08/2024

Continuous trademark protection

Get notified about every new filing that threatens GOZELLIX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.